There is good news for HIV-positive men who are in the majority of those who suffer from low testosterone.
Lance Feeney discusses how gay men can decrease the chance of developing anal cancer.
It is a little over a year since the Positive Life NSW President Malcolm Leech died of anal cancer and I’ve been thinking of him and his commitment to the myriad of health and social issues faced by peoples’ living with HIV. I’ve come to realise that we need to avert other deaths from anal cancer in gay men and people with HIV.
HIV advocates and researchers admit that many people do not use condoms. Now there are revolutionary new ways of preventing HIV infection including taking a pill day.
A new $7 million grant for the Anova Health Institute’s Health4Men project to address HIV in South Africa’s gay, bisexual and MSM (men who have sex with men) community has been announced in both Washington and Johannesburg. This significant international funding boost to expand MSM-targeted HIV-related services in South Africa is the result of a new partnership between the Elton John AIDS Foundation and the US President’s Emergency Plan for AIDS Relief (PEPFAR).
On October 10, the U.S. Food and Drug Administration (FDA) approved a new once-daily combination pill for the treatment of genotype 1 chronic hepatitis C containing Gilead Sciences’ HCV nucleotide polymerase inhibitor sofosbuvir (Sovaldi) plus ledipasvir, the first approved HCV NS5A inhibitor.
Use of prescription erectile dysfunction (ED) medication was significantly associated with sexual risk behavior in HIV-positive men, according to data presented at IDWeek 2014 by Greer Burkholder, MD, of the Infectious Diseases Department, University of Alabama at Birmingham.
To help address the HIV epidemic among young members of key populations, the United Nations Interagency Working Group on Key Populations has produced a series of technical briefs focused on the needs and realities of young men who have sex with men, young people who sell sex, young people who use drugs, and young transgender people.
Two new studies indicate differences in treatment among racial groups.